Professor Mark Davis

AMR IMPACT THEME

  • Publics, AMR Prevention & Care

EXPERTISE

  • Medical sociology
  • Public engagements with biomedical science and technology
  • Infection and immunity
  • Pharmaceuticals
  • Digital health

Professor Mark Davis leads an interdisciplinary programme of research on general and minority public engagements with biomedical science and technology, focussed particularly on infection and immunity, pharmaceuticals, and digital health. His research has been supported by research council and government organisations, including the ARC, ESRC, and the NHS. He is the lead investigator for ’Building the Australian response to the superbugs crisis’,‘The sociology of antibiotics and the antimicrobial resistance crisis’ and chief investigator on ‘Navigating an uncertain antimicrobial future: a sociological study’.

Professor Davis was awarded his doctorate in Sociology (2005) from the Institute of Education, University College London. He previously worked as a psychologist for government and in HIV prevention and research. He has held research positions at Royal Free and UCL Medical School, Imperial College Medical School, and the Institute of Health Sciences, City University London. From 2004, he was a Senior Lecturer in Psychosocial Studies, University of East London. Associate Professor Mark joined Monash University in 2007 and received the Dean’s Award for Excellence in Early Career Research in 2012 and the Monash Research Accelerator Award in 2013. In 2022 the six-part podcast series “Rise of the Superbugs” (produced as part of an ARC-funded AMR project led by Professor Davis) was awarded bronze at the Australian Podcast Awards (Education). Evidence of his commitment to communicating and exploring the role of social science in AMR, Professor Davis convenes the Social Science Network in AMR webinar series.

AMR FOCUS

  • Examining news, social & health media communications about microbial life, antimicrobials, resistance & stewardship.
  • Understanding lived experience: infection, immunity, antibiotics & AMR.
  • Investigating digital media based antimicrobial stewardship in the general population.
  • Exploring the enablers & barriers for the safe use of antibiotics in human & companion animal health.
  • Understanding social & organisational drivers of antimicrobial stewardship in clinical settings.
  • Investigating science & policy of One Health as applied to AMR.

IMPACT

  • Developing theory- and evidence based approaches to general population antimicrobial stewardship communications.
  • Informing national/state policy & communications on AMR & stewardship.

LEADERSHIP

HIGHLIGHTS